Company intelligence / Profile preview

Nanoshift

Emeryville, California, United Statesnanoshift.net ↗

Ownership: Private
Employees: ~7
Development stage: Commercial

Overview

Nanoshift specializes in advanced wafer-level processing and custom fabrication of microfluidic devices, MEMS components, biochips, gene sequencing chips, and cell sorting devices. Their technologies are used in life science research tools and medical diagnostics. They have supported clinical trials as collaborators or technology providers but do not develop drugs themselves. For example, they have been involved with clinical studies using their NanoDOX® hydrogel delivery system for wound healing applications.

Modalities: DeviceMicrofluidic deviceDiagnostic tool
Industry: Molecular Diagnostics

Partnerships

Notable collaborations include academic hospitals such as The General Hospital Corp. for clinical trials involving their device platforms or materials like NanoDOX® hydrogel delivery systems

Beyond the preview

Go deeper on Nanoshift.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanoshift.

Explore the full profile